CD274 and squamous cell carcinoma: However, in subgroups with squamous cell carcinoma (SCC), stage III disease, and PD‐L1 expression level subgroups (>50% and 1–49%), although OS and PFS showed a trend toward shortening in the severe group, the differences were not statistically significant.